BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30995391)

  • 1. Combination of Double-Mediator System with Large-Scale Integration-Based Amperometric Devices for Detecting NAD(P)H:quinone Oxidoreductase 1 Activity of Cancer Cell Aggregates.
    Ino K; Onodera T; Fukuda MT; Nashimoto Y; Shiku H
    ACS Sens; 2019 Jun; 4(6):1619-1625. PubMed ID: 30995391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemical monitoring of intracellular enzyme activity of single living mammalian cells by using a double-mediator system.
    Matsumae Y; Takahashi Y; Ino K; Shiku H; Matsue T
    Anal Chim Acta; 2014 Sep; 842():20-6. PubMed ID: 25127647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells.
    Gray JP; Karandrea S; Burgos DZ; Jaiswal AA; Heart EA
    Toxicol Lett; 2016 Nov; 262():1-11. PubMed ID: 27558805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation of NAD(P)H:quinone oxidoreductase 1 and UDP-glucuronosyltransferases reduces menadione cytotoxicity in HEK293 cells.
    Nishiyama T; Izawa T; Usami M; Ohnuma T; Ogura K; Hiratsuka A
    Biochem Biophys Res Commun; 2010 Apr; 394(3):459-63. PubMed ID: 20035715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q cytoprotective mechanisms for mitochondrial complex I cytopathies involves NAD(P)H: quinone oxidoreductase 1(NQO1).
    Chan TS; Teng S; Wilson JX; Galati G; Khan S; O'Brien PJ
    Free Radic Res; 2002 Apr; 36(4):421-7. PubMed ID: 12069106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UDP-glucuronosyltransferases 1A6 and 1A10 catalyze reduced menadione glucuronidation.
    Nishiyama T; Ohnuma T; Inoue Y; Kishi T; Ogura K; Hiratsuka A
    Biochem Biophys Res Commun; 2008 Jun; 371(2):247-50. PubMed ID: 18423374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A physiological threshold for protection against menadione toxicity by human NAD(P)H:quinone oxidoreductase (NQO1) in Chinese hamster ovary (CHO) cells.
    De Haan LH; Boerboom AM; Rietjens IM; van Capelle D; De Ruijter AJ; Jaiswal AK; Aarts JM
    Biochem Pharmacol; 2002 Dec; 64(11):1597-603. PubMed ID: 12429349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pulmonary arterial endothelial cells on quinone redox status: effect of hyperoxia-induced NAD(P)H:quinone oxidoreductase 1.
    Merker MP; Audi SH; Bongard RD; Lindemer BJ; Krenz GS
    Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L607-19. PubMed ID: 16243901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemicolor Imaging Using an LSI-Based Device for Multiplexed Cell Assays.
    Kanno Y; Ino K; Abe H; Sakamoto C; Onodera T; Inoue KY; Suda A; Kunikata R; Matsudaira M; Shiku H; Matsue T
    Anal Chem; 2017 Dec; 89(23):12778-12786. PubMed ID: 29090905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones.
    Glorieux C; Sandoval JM; Dejeans N; Ameye G; Poirel HA; Verrax J; Calderon PB
    Life Sci; 2016 Jan; 145():57-65. PubMed ID: 26687450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo.
    Dehn DL; Siegel D; Zafar KS; Reigan P; Swann E; Moody CJ; Ross D
    Mol Cancer Ther; 2006 Jul; 5(7):1702-9. PubMed ID: 16891456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrochemical Motion Tracking of Microorganisms Using a Large-Scale-Integration-Based Amperometric Device.
    Ino K; Kanno Y; Inoue KY; Suda A; Kunikata R; Matsudaira M; Shiku H; Matsue T
    Angew Chem Int Ed Engl; 2017 Jun; 56(24):6818-6822. PubMed ID: 28471045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.
    Siegel D; Gustafson DL; Dehn DL; Han JY; Boonchoong P; Berliner LJ; Ross D
    Mol Pharmacol; 2004 May; 65(5):1238-47. PubMed ID: 15102952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
    den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
    Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of NAD(P)H:quinone oxidoreductase encoded by drgA gene in reduction of exogenous quinones in cyanobacterium Synechocystis sp. PCC 6803 cells.
    Elanskaya IV; Grivennikova VG; Groshev VV; Kuznetsova GV; Semina ME; Timofeev KN
    Biochemistry (Mosc); 2004 Feb; 69(2):137-42. PubMed ID: 15000679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity.
    Joseph P; Long DJ; Klein-Szanto AJ; Jaiswal AK
    Biochem Pharmacol; 2000 Jul; 60(2):207-14. PubMed ID: 10825465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Menadione-Mediated WST1 Reduction by Cultured Astrocytes Depends on NQO1 Activity and Cytosolic Glucose Metabolism.
    Ehrke E; Steinmeier J; Stapelfeldt K; Dringen R
    Neurochem Res; 2021 Jan; 46(1):88-99. PubMed ID: 31902045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
    Dehn DL; Winski SL; Ross D
    Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells.
    Bongard RD; Lindemer BJ; Krenz GS; Merker MP
    Free Radic Biol Med; 2009 Jan; 46(1):25-32. PubMed ID: 18848878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo relevance of two critical levels for NAD(P)H:quinone oxidoreductase (NQO1)-mediated cellular protection against electrophile toxicity found in vitro.
    de Haan LH; Pot GK; Aarts JM; Rietjens IM; Alink GM
    Toxicol In Vitro; 2006 Aug; 20(5):594-600. PubMed ID: 16314070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.